138 related articles for article (PubMed ID: 21905596)
21. Comparison between azithromycin and amoxicillin in the treatment of infectious exacerbation of chronic obstructive pulmonary disease.
Andre-Alves MR; Jardim JR; Frare e Silva R; Fiss E; Freire DN; Teixeira PJ
J Bras Pneumol; 2007; 33(1):43-50. PubMed ID: 17568867
[TBL] [Abstract][Full Text] [Related]
22. Safety and Tolerability of Nebulized Amoxicillin-Clavulanic Acid in Patients with COPD (STONAC 1 and STONAC 2).
Nijdam LC; Assink MD; Kuijvenhoven JC; de Saegher ME; van der Valk PD; van der Palen J; Brusse-Keizer MG; Movig KL
COPD; 2016 Aug; 13(4):448-54. PubMed ID: 26744171
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of exacerbations of chronic obstructive pulmonary disease with pristinamycin].
Léophonte P; Chidiac C; Drugeon HB; Strabach S; Cabrillac-Rives S; Chone C; Dellatolas F; Safran C
Rev Mal Respir; 2004 Apr; 21(2 Pt 1):261-71. PubMed ID: 15211234
[TBL] [Abstract][Full Text] [Related]
24. Trovafloxacin versus amoxicillin/clavulanic acid in the treatment of acute exacerbations of chronic obstructive bronchitis.
Léophonte P; Baldwin RJ; Pluck N
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):434-40. PubMed ID: 9758289
[TBL] [Abstract][Full Text] [Related]
25. Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study.
Gris P
J Antimicrob Chemother; 1996 Jun; 37 Suppl C():93-101. PubMed ID: 8818850
[TBL] [Abstract][Full Text] [Related]
26. More evidence is required for short-term treatment of exacerbations of chronic obstructive pulmonary disease: 3 days or no antibiotic at all?
Llor C; Miravitlles M
Clin Microbiol Infect; 2007 Jul; 13(7):748-9. PubMed ID: 17501972
[No Abstract] [Full Text] [Related]
27. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.
Bathoorn E; Groenhof F; Hendrix R; van der Molen T; Sinha B; Kerstjens HA; Friedrich AW; Kocks JW
Int J Chron Obstruct Pulmon Dis; 2017; 12():285-290. PubMed ID: 28144133
[TBL] [Abstract][Full Text] [Related]
28. Treatment of acute exacerbation of severe-to-very severe COPD with azithromycin in patients vaccinated against Streptococcus pneumoniae.
Cazzola M; Salzillo A; De Giglio C; Piccolo A; Califano C; Noschese P
Respir Med; 2005 Jun; 99(6):663-9. PubMed ID: 15878482
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the efficacy, tolerability and safety of azithromycin and co-amoxiclav in the treatment of sinusitis in adults.
Clement PA; de Gandt JB
J Int Med Res; 1998; 26(2):66-75. PubMed ID: 9602984
[TBL] [Abstract][Full Text] [Related]
30. A multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis.
Schaberg T; Ballin I; Huchon G; Bassaris H; Hampel B; Reimnitz P;
J Int Med Res; 2001; 29(4):314-28. PubMed ID: 11675905
[TBL] [Abstract][Full Text] [Related]
31. Exacerbation of chronic obstructive pulmonary disease: a role of antibiotics?
Rapić M
Coll Antropol; 2014 Dec; 38 Suppl 2():223-6. PubMed ID: 25643555
[TBL] [Abstract][Full Text] [Related]
32. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
[TBL] [Abstract][Full Text] [Related]
33. Modulation of biofilm of strains isolated from patients with chronic obstructive pulmonary disease by levofloxacin, moxifloxacin, ciprofloxacin, amoxicillin/clavulanic acid and ceftriaxone.
Drago L; Mattina R; Legnani D; Romano CL; Vianello E; Ricci C; De Vecchi E
Int J Immunopathol Pharmacol; 2011; 24(4):1027-35. PubMed ID: 22230408
[TBL] [Abstract][Full Text] [Related]
34. [Antibiotics for acute exacerbations of chronic obstructive pulmonary disease (COPD)].
Burgel PR
Med Mal Infect; 2006; 36(11-12):706-17. PubMed ID: 16839731
[TBL] [Abstract][Full Text] [Related]
35. Study of Pre-disposing Factors of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Antibiotic Prescribing Pattern with Reference to Antibiotic Sensitivity Test.
Shrestha R; Shrestha B; Shakya Shrestha S; Pant A; Prajapati B; Karmacharya BM
Kathmandu Univ Med J (KUMJ); 2015; 13(51):250-5. PubMed ID: 27180373
[TBL] [Abstract][Full Text] [Related]
36. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.
Sethi S; Evans N; Grant BJ; Murphy TF
N Engl J Med; 2002 Aug; 347(7):465-71. PubMed ID: 12181400
[TBL] [Abstract][Full Text] [Related]
37. Randomised double-blind comparison of oral gatifloxacin and co-amoxiclav for acute exacerbation of chronic Bronchitis.
Solèr M; Lode H; Baldwin R; Levine JH; Schreurs AJ; van Noord JA; Maesen FP; Zehrer M;
Eur J Clin Microbiol Infect Dis; 2003 Mar; 22(3):144-50. PubMed ID: 12649711
[TBL] [Abstract][Full Text] [Related]
38. Chronic obstructive pulmonary disease: role of bacteria and guide to antibacterial selection in the older patient.
Murphy TF; Sethi S
Drugs Aging; 2002; 19(10):761-75. PubMed ID: 12390053
[TBL] [Abstract][Full Text] [Related]
39. Comparison of cefuroxime and co-amoxiclav in the treatment of acute sinusitis in a sample of the Iranian population.
Lari AR; Alinejad F; Alaghehbandan R; Mostafavi H; Asghari B; Gholami A
Infez Med; 2012 Dec; 20(4):251-5. PubMed ID: 23299064
[TBL] [Abstract][Full Text] [Related]
40. Comparison of roxithromycin with co-amoxiclav in patients with sinusitis.
Chatzimanolis E; Marsan N; Lefatzis D; Pavlopoulos A
J Antimicrob Chemother; 1998 Mar; 41 Suppl B():81-4. PubMed ID: 9579718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
